News

January 20, 2020
A Disruptive Approach to Oncology Therapy Development

A Disruptive Approach to Oncology Therapy Development

CureLab Oncology CEO Alex Shneider’s lament is a biopharma industry that exhibits little appetite for those discoveries made while coloring outside the lines